54:1969S-1975S
(In fact, a derivative of MT2, Bremelanotide, is a clinically approved treatment)
T., Singh Ospina, N., Kotecha, P., Lu, Y., Tong, J., Smith, S
Lymphatic targeting may be achieved via the delivery of macromolecular therapeutics (for example, proteins and peptides), small-molecule therapeutics in association with macromolecular carriers (for example, nanoparticles, polymers, liposomes and dendrimers) or small-molecule therapeutics that associate, in situ , with endogenous macromolecular constructs (for example, lipoproteins and proteins) or cells that are transported from interstitial tissues via lymphatic rather than blood capillaries
15% Vitamin C serum with tetrahexyldecyl ascorbate, ferulic acid, and peptides, that visibly brighten and firm, reduce dark spots, and redness